We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
+13.66%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$808M
AUM Growth
+$124M
Cap. Flow
+$79.6M
Cap. Flow %
9.85%
Top 10 Hldgs %
10.76%
Holding
1,192
New
451
Increased
150
Reduced
140
Closed
446

Top Buys

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$8.73M
2
LULU icon
lululemon athletica
LULU
+$8.28M
3
BLK icon
Blackrock
BLK
+$8.25M
4
CRWD icon
CrowdStrike
CRWD
+$8.15M
5
SPGI icon
S&P Global
SPGI
+$7.53M

Sector Composition

Rank Sector Weight
1 Technology 22.71%
2 Healthcare 15.54%
3 Consumer Discretionary 15.12%
4 Financials 10.8%
5 Industrials 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SKIN icon
276
SkinHealth Systems
SKIN
$86.3M
$796K 0.1%
+62,998
New +$729K
TLRY icon
277
Tilray
TLRY
$478M
$792K 0.1%
31,300
+28,330
+954% +$808K
PBA icon
278
Pembina Pipeline
PBA
$29.4B
$781K 0.1%
24,100
+4,700
+24% +$159K
NEX
279
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$778K 0.1%
97,800
+82,200
+527% +$735K
UPST icon
280
Upstart Holdings
UPST
$2.53B
$775K 0.1%
+48,800
New +$821K
ATO icon
281
Atmos Energy
ATO
$30.2B
$775K 0.1%
+6,900
New +$785K
SRE icon
282
Sempra
SRE
$59.4B
$771K 0.1%
10,200
-9,200
-47% -$706K
TMDX icon
283
Transmedics
TMDX
$2.61B
$760K 0.09%
10,035
+900
+10% +$62.2K
IONS icon
284
Ionis Pharmaceuticals
IONS
$9.12B
$759K 0.09%
+21,227
New +$797K
TJX icon
285
TJX Companies
TJX
$179B
$754K 0.09%
+9,628
New +$758K
GEN icon
286
Gen Digital
GEN
$16.7B
$753K 0.09%
43,900
-9,900
-18% -$199K
DLB icon
287
Dolby
DLB
$5B
$752K 0.09%
+8,805
New +$711K
BE icon
288
Bloom Energy
BE
$46.6B
$750K 0.09%
+37,628
New +$824K
TENB icon
289
Tenable Holdings
TENB
$3.51B
$749K 0.09%
+15,770
New +$670K
AOS icon
290
A.O. Smith
AOS
$8.58B
$749K 0.09%
10,828
+3,800
+54% +$247K
LVS icon
291
Las Vegas Sands
LVS
$32.1B
$747K 0.09%
+13,000
New +$728K
EVH icon
292
Evolent Health
EVH
$398M
$746K 0.09%
+22,976
New +$727K
FCN icon
293
FTI Consulting
FCN
$5.17B
$742K 0.09%
3,759
ARDX icon
294
Ardelyx
ARDX
$1.24B
$742K 0.09%
154,849
+138,149
+827% +$466K
COO icon
295
Cooper Companies
COO
$14.2B
$733K 0.09%
+7,856
New +$675K
CZR icon
296
Caesars Entertainment
CZR
$6.06B
$732K 0.09%
14,994
-609
-4% -$29.9K
GTLS
297
DELISTED
Chart Industries
GTLS
$731K 0.09%
5,833
-800
-12% -$103K
EHC icon
298
Encompass Health
EHC
$11.4B
$730K 0.09%
+13,500
New +$786K
CARG icon
299
CarGurus
CARG
$3.34B
$730K 0.09%
+39,086
New +$665K
EVBG
300
DELISTED
Everbridge, Inc. Common Stock
EVBG
$727K 0.09%
20,958
+13,700
+189% +$438K

Similar funds

Bayesian Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Bayesian Capital Management held 1,192 positions worth $808M, up 18% from $684M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Bayesian Capital Management deployed $79.6M of net new capital in Q1 2023, opening 451 new positions and adding to 150 existing holdings. Its largest new stake was lululemon athletica: 26,400 shares worth $9.61M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $81M trimmed.

  • Bayesian Capital Management's largest Q1 2023 buy was lululemon athletica: 26,400 shares worth $9.61M.
  • Bayesian Capital Management added most to Cisco in Q1 2023, an estimated $8.73M increase.
  • Bayesian Capital Management's biggest Q1 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $81M.
  • Bayesian Capital Management fully exited Meta Platforms (Facebook) in Q1 2023, selling an estimated $9.71M.
  • Bayesian Capital Management's ten largest holdings make up 11% of its $808M portfolio in Q1 2023.
  • Bayesian Capital Management opened 451 new positions and closed 446 in Q1 2023.
  • Bayesian Capital Management's portfolio value rose 18% quarter-over-quarter to $808M.

Based on Bayesian Capital Management's 13F filing for Q1 2023, filed 15 May 2023.